Physician
Emergency Medicine
Dr. Ana M. Ibrado, MD
|
|
Give Review
Ibrado works in the field of Emergency Medicine. She attended Medical University of South Carolina College of Medicine. Dr. Ana M. Ibrado is a published doctor and has 17 publications published. The lastest was: 'Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AM...' She is registered with Medicare and accepts Medicare payments.
Publications
- Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors.
- Temporal relationship of CDK1 activation and mitotic arrest to cytosolic accumulation of cytochrome C and caspase-3 activity during Taxol-induced apoptosis of human AM...
- Effects of modulators of protein kinases on taxol-induced apoptosis of human leukemic cells possessing disparate levels of p26BCL-2 protein.
- Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.
- Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells.
- Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
- Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.
- Co-expression of several molecular mechanisms of multidrug resistance and their significance for paclitaxel cytotoxicity in human AML HL-60 cells.
- Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated...
- Intracellular metabolism of Ara-C and resulting DNA fragmentation and apoptosis of human AML HL-60 cells possessing disparate levels of Bcl-2 protein.
- Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
- Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
- 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation.
- Characterization of a human myeloid leukemia cell line highly resistant to taxol.
- Combined antileukemic activity of pIXY 321 and Ara-C against human acute myeloid leukemia cells.
- pIXY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells.
Schools
Medical University of South Carolina
Johns Hopkins University Hospital
Doctors Specialties
- Emergency Medicine
Accepted Insurances
Education
-
Johns Hopkins University -
Medical University of South Carolina College of Medicine
Drug Facts
| NPI NUMBER | 1851376529 | |
| NPPES Provider LastName | IBRADO | |
| NPPES Provider FirstName | ANA | |
| NPPES Provider ZIPCode | 20017 | |
| NPPES Provider State | DC | |
| Specialty Description | Emergency Medicine | |
| Total Claim Count | 45.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1851376529 |
| Last Name Of The Provider | IBRADO |
| First Name Of The Provider | ANA |
| View All |
Similar Doctors
|
|
Dr. Lara Vanyo, MD |
|
|
Dr. Lemeneh Tefera, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norman A. Brown, MD |
|
|
Dr. Jared B. Goldberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley A. Boucree Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James L. Steward Jr., MD |
|
|
Dr. Matthew Wilson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cynthia Roseberry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew Jacques, MD
This Doctor is OpenDoctor Recommended.
|